Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
27.02.23 | AppHarvest announces closing of public offering of common stock and full exercise of underwriters' option to purchase additional shares | 187 | GlobeNewswire (Europe) | MOREHEAD, Ky., Feb. 27, 2023 (GLOBE NEWSWIRE) -- AppHarvest, Inc. (NASDAQ: APPH, APPHW), a sustainable food company, public benefit corporation and Certified B Corp building some of the world's largest... ► Artikel lesen | |
27.02.23 | VERSES Announces Convertible Debenture Financing of up to C$5,000,000 | 377 | GlobeNewswire (Europe) | VANCOUVER, British Columbia, Feb. 27, 2023 (GLOBE NEWSWIRE) -- VERSES Technologies Inc. (NEO:VERS) (OTCQX:VRSSF) ("VERSES' or the "Company"), a cognitive computing company specializing in the next generation... ► Artikel lesen | |
27.02.23 | Adamis Pharmaceuticals Corporation: Adamis Pharmaceuticals and DMK Pharmaceuticals Announce Agreement and Plan of Merger | 225 | GlobeNewswire (Europe) | Combined company will have commercial products and a library of development candidates, two of which are clinical stageWill be under the leadership of DMK CEO, Dr. Ebrahim (Eboo) Versi MD, PhDLead development... ► Artikel lesen | |
27.02.23 | Nasdaq, Inc.: Nasdaq Announces Mid-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date February 15, 2023 | 222 | GlobeNewswire (Europe) | NEW YORK, Feb. 27, 2023 (GLOBE NEWSWIRE) -- At the end of the settlement date of February 15, 2023, short interest in 3,455 Nasdaq Global MarketSM securities totaled 9,937,951,277 shares compared with... ► Artikel lesen | |
27.02.23 | Safe Orthopaedics: Effective date of the reverse split and first listing of the new consolidated shares | 407 | GlobeNewswire (Europe) | Effective date of the reverse split and first listing... ► Artikel lesen | |
27.02.23 | Stellantis N.V.: Stellantis Announces Strategic Copper Investment in Argentina, Reinforcing Commitment to Reaching Carbon Net Zero by 2038 | 326 | GlobeNewswire (Europe) | Stellantis Announces Strategic Copper Investment in Argentina, Reinforcing Commitment to Reaching Carbon Net Zero by 2038 $155 million investment in McEwen Copper helps Stellantis secure projected copper... ► Artikel lesen | |
27.02.23 | Eimskipafelag Islands hf.: Candidates to the Board of Directors and 2023 AGM's final agenda | 272 | GlobeNewswire (Europe) | Enclosed is information on candidates to the Board of Directors of Eimskipafélag Íslands hf. to be elected at the Annual General Meeting 9 March 2023. Deadline for declaring candidacy has passed. According... ► Artikel lesen | |
27.02.23 | Atrion Corporation: Atrion Reports Fourth Quarter and Full Year 2022 Results | 375 | GlobeNewswire (Europe) | ALLEN, Texas, Feb. 27, 2023 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ: ATRI) today announced its results for the fourth quarter ended December 31, 2022 and the full year 2022. Revenues for the... ► Artikel lesen | |
27.02.23 | Chinook Therapeutics, Inc.: Chinook Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Updates | 380 | GlobeNewswire (Europe) | SEATTLE, Feb. 27, 2023 (GLOBE NEWSWIRE) -- Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical company focused on the discovery, development and commercialization of precision medicines for... ► Artikel lesen | |
27.02.23 | Inari Medical, Inc.: Inari Medical Reports Fourth Quarter and Full Year 2022 Financial Results | 583 | GlobeNewswire (Europe) | IRVINE, Calif., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) ("Inari"), a medical device company with a mission to treat and transform the lives of patients suffering from venous... ► Artikel lesen | |
27.02.23 | FibroGen, Inc.: FibroGen Reports Fourth Quarter and Full Year 2022 Financial Results | 387 | GlobeNewswire (Europe) | Topline Data from Five Pivotal Phase 3 Trials in 2023Total Company Revenue $140.7 Million in 2022Continued Strong Roxadustat Volume Growth in China SAN FRANCISCO, Feb. 27, 2023 (GLOBE NEWSWIRE) -- FibroGen... ► Artikel lesen | |
27.02.23 | Denali Therapeutics Inc.: Denali Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Business Highlights | 564 | GlobeNewswire (Europe) | SOUTH SAN FRANCISCO, Calif., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (Nasdaq: DNLI), a biopharmaceutical company developing a broad portfolio of product candidates engineered to cross... ► Artikel lesen | |
27.02.23 | Vaxcyte, Inc.: Vaxcyte Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update | 560 | GlobeNewswire (Europe) | -- Company Received U.S. Food and Drug Administration (FDA) Clearance of VAX-24 Infant Investigational New Drug (IND) Application and Expects to Initiate Phase 2 Study in Second Quarter 2023 -- -- Topline... ► Artikel lesen | |
27.02.23 | Progyny, Inc. Announces Fourth Quarter 2022 Results | 474 | GlobeNewswire (Europe) | Reports Full Year Revenue of $786.9 Million, Reflecting 57% GrowthReports Record Quarterly Revenue and Operating Cash Flow of $214.3 Million and $51.5 Million, RespectivelyIssues Financial Guidance... ► Artikel lesen | |
27.02.23 | Dril-Quip, Inc. Announces Fourth Quarter and Full Year 2022 Results | 454 | GlobeNewswire (Europe) | Fourth quarter and full year revenue increase double digits year-over-yearSignificant progress made along operational excellence initiativesCompany provides fiscal 2023 financial outlook HOUSTON, Feb.... ► Artikel lesen | |
27.02.23 | TaskUs Holdings, Inc.: TaskUs Announces Fiscal Fourth Quarter and Full Year 2022 Results | 589 | GlobeNewswire (Europe) | FY 2022 Revenue and Adjusted EBITDA Above Most Recent OutlookOver 26% Revenue Growth in FY 2022Added 40 Clients in FY 2022Number of Clients over $1 Million in Revenue Increased by 19% in FY 2022; Number... ► Artikel lesen | |
27.02.23 | EverQuote, Inc.: EverQuote Announces Fourth Quarter and Full Year 2022 Financial Results | 444 | GlobeNewswire (Europe) | Fourth Quarter Revenue of $88.3 millionFourth Quarter Variable Marketing Margin of $29.1 millionFull Year Revenue of $404.1 millionFull Year Variable Marketing Margin of $128.3 million CAMBRIDGE, Mass.... ► Artikel lesen | |
27.02.23 | Revolution Medicines, Inc.: Revolution Medicines Reports Fourth Quarter and Full Year 2022 Financial Results and Update on Corporate Progress | 527 | GlobeNewswire (Europe) | Early clinical data on RMC-6236 provided in support of RAS(ON) Inhibitor platform validation Additional data releases for RMC-6236 (RASMULTI) and RMC-6291 (KRASG12C) expected in 2023 RMC-9805 (KRASG12D)... ► Artikel lesen | |
27.02.23 | Zoom Video Communications, Inc.: Zoom Video Communications Reports Fourth Quarter and Fiscal Year 2023 Financial Results | 226 | GlobeNewswire (Europe) | Fourth quarter total revenue of $1,117.8 million, up 4% year over year as reported and 6% in constant currency; full fiscal year total revenue of $4,393.0 million, up 7% year over year as reported and... ► Artikel lesen | |
27.02.23 | SI-BONE, Inc. Reports Fourth Quarter and Full Year 2022 Financial Results and Issues 2023 Guidance | 536 | GlobeNewswire (Europe) | SANTA CLARA, Calif., Feb. 27, 2023 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq:SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today reported... ► Artikel lesen |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
EVOTEC | 6.082 |
NVIDIA | 4.156 |
TUI | 3.346 |
GAMESTOP | 3.342 |
BAYER | 2.575 |
NEL | 2.431 |
RHEINMETALL | 2.061 |
BYD | 1.915 |
DEUTSCHE LUFTHANSA | 1.648 |
TESLA | 1.391 |
VOLKSWAGEN | 1.170 |
SUPER MICRO COMPUTER | 1.120 |
CARL ZEISS MEDITEC | 1.105 |
CAVENDISH HYDROGEN | 1.045 |
APPLE | 951 |
AIXTRON SE | 937 |
BASF | 929 |
THYSSENKRUPP | 924 |
DEFI TECHNOLOGIES | 902 |
COMMERZBANK | 880 |
DEUTSCHE BANK | 790 |
PORSCHE SE | 769 |
RENK GROUP | 763 |
PLUG POWER | 737 |
BROADCOM | 728 |